Feature | August 17, 2012

Breast Tomosynthesis System

The Selenia Dimensions system is the first commercially available tool to deliver on the promise of breast tomosynthesis, an innovation poised to revolutionize how breast cancer is detected today. Approved for sale in the United States in February 2011, the tomosynthesis system directly addresses the primary limitations of conventional 2-D mammography — the superimposition of normal breast tissue.

Hologic Inc. showed the Selenia Dimensions system at AHRA 2012.

For more information: www.hologic.com

Related Content

Cianna Medical featured its wire-free marker system on the exhibit floor of the breast imaging symposium in Hollywood, Fla.

Cianna Medical featured its wire-free marker system on the exhibit floor of the breast imaging symposium in Hollywood, Fla.

Feature | Breast Imaging | April 24, 2019 | By Greg Freiherr

Productivity and Patient Benefits May Come From Wire-free Lumpectomy

Wires have traditionally been placed prior to lumpectomy to mark cancerous tissues in the breast.

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium in Hollywood, Florida. Photo by Greg Freiherr

Feature | Breast Imaging | April 23, 2019 | By Greg Freiherr

Vendor Strategies Provide Glimpse of Women’s Health Future

Signs of what the future may look like in women’s health dotted the exhibit floor of the...

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr

Development of Artificial Intelligence in Women’s Health Emphasizes Value

Commercial efforts to develop...

Videos | Breast Imaging | April 18, 2019

VIDEO: Age, Interval and Other Considerations for Breast Screening

In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr

How Risk Stratification Might Affect Women’s Health

When planning a screening program to detect the early signs of breast cancer, age is a major consideration.

Videos | Artificial Intelligence | April 17, 2019

VIDEO: Artificial Intelligence in Radiology — Are We Doomed?

At the Society of Breast Imagi...

News | Radiology Business | April 16, 2019

iCAD Appoints Stacey Stevens as President

iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...

360 Photos | 360 View Photos | April 16, 2019

360 Degree View of a Hologic 3-D Mammography System

A 360 view of a simulated breast compression for a...

Videos | Mammography | April 15, 2019

VIDEO: A Discussion on Proposed FDA Rules for Mammography Reporting

Wendie Berg, M.D., Ph.D., FACR

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used “Deep Learning,“ a form of machine learning, which is a type of artificial intelligence. Graphic courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Artificial Intelligence | April 12, 2019 | By Greg Freiherr

AI Algorithm Detects Breast Cancer in MR Images

The use of smart algorithms has the potential to make healthcare more efficient.